These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 27448026)

  • 1. Sensitive and Selective Detection of HIV-1 RRE RNA Using Vertical Silicon Nanowire Electrode Array.
    Lee J; Hong MH; Han S; Na J; Kim I; Kwon YJ; Lim YB; Choi HJ
    Nanoscale Res Lett; 2016 Dec; 11(1):341. PubMed ID: 27448026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Large current difference in Au-coated vertical silicon nanowire electrode array with functionalization of peptides.
    Kim I; Kim SE; Han S; Kim H; Lee J; Jeong DW; Kim JJ; Lim YB; Choi HJ
    Nanoscale Res Lett; 2013 Nov; 8(1):502. PubMed ID: 24279451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluorescence-based methods for evaluating the RNA affinity and specificity of HIV-1 Rev-RRE inhibitors.
    Luedtke NW; Tor Y
    Biopolymers; 2003 Sep; 70(1):103-19. PubMed ID: 12925996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evolvability of the mode of peptide binding by an RNA.
    Iwazaki T; Li X; Harada K
    RNA; 2005 Sep; 11(9):1364-73. PubMed ID: 16043495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An isostructural G-G to A-A substitution within the HIV RRE RNA switches the specificity towards arginine-rich peptides.
    Aoyama S; Sugaya M; Kobayashi C; Masuda K; Maeda T; Sakamoto T; Kawai G; Katoh A; Harada K
    Nucleic Acids Symp Ser (Oxf); 2009; (53):271-2. PubMed ID: 19749365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Water, shape recognition, salt bridges, and cation-pi interactions differentiate peptide recognition of the HIV rev-responsive element.
    Michael LA; Chenault JA; Miller BR; Knolhoff AM; Nagan MC
    J Mol Biol; 2009 Sep; 392(3):774-86. PubMed ID: 19631217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of human immunodeficiency virus type 1 in human T cells by a potent Rev response element decoy consisting of the 13-nucleotide minimal Rev-binding domain.
    Lee SW; Gallardo HF; Gilboa E; Smith C
    J Virol; 1994 Dec; 68(12):8254-64. PubMed ID: 7966618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Derivation of primary sequences and secondary structures of rev responsive element from HIV-1 infected mothers and infants following vertical transmission.
    Ramakrishnan R; Ahmad N
    Virology; 2007 Mar; 359(1):201-11. PubMed ID: 17045321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RNA-ligand interactions: affinity and specificity of aminoglycoside dimers and acridine conjugates to the HIV-1 Rev response element.
    Luedtke NW; Liu Q; Tor Y
    Biochemistry; 2003 Oct; 42(39):11391-403. PubMed ID: 14516190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stereospecificity of short Rev-derived peptide interactions with RRE IIB RNA.
    Litovchick A; Rando RR
    RNA; 2003 Aug; 9(8):937-48. PubMed ID: 12869705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A ratiometric fluorescence RRE RNA-targeted assay for a new fluorescence ligand.
    Qi L; Wei JR; Lv XJ; Huo Y; Zhang ZQ
    Biosens Bioelectron; 2016 Dec; 86():287-292. PubMed ID: 27387258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of neomycin and Rev peptide binding to the Rev responsive element of HIV-1 as determined by fluorescence and NMR spectroscopy.
    Lacourciere KA; Stivers JT; Marino JP
    Biochemistry; 2000 May; 39(19):5630-41. PubMed ID: 10801313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amino acid requirement for the high affinity binding of a selected arginine-rich peptide with the HIV Rev-response element RNA.
    Sugaya M; Nishino N; Katoh A; Harada K
    J Pept Sci; 2008 Aug; 14(8):924-35. PubMed ID: 18351707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trafficking through the Rev/RRE pathway is essential for efficient inhibition of human immunodeficiency virus type 1 by an antisense RNA derived from the envelope gene.
    Ward AM; Rekosh D; Hammarskjold ML
    J Virol; 2009 Jan; 83(2):940-52. PubMed ID: 18971264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamics of RNA-protein interactions in the HIV-1 Rev-RRE complex visualized by 6-thioguanosine-mediated photocrosslinking.
    Ping YH; Liu Y; Wang X; Neenhold HR; Rana TM
    RNA; 1997 Aug; 3(8):850-60. PubMed ID: 9257644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arginine side-chain dynamics in the HIV-1 rev-RRE complex.
    Wilkinson TA; Botuyan MV; Kaplan BE; Rossi JJ; Chen Y
    J Mol Biol; 2000 Nov; 303(4):515-29. PubMed ID: 11054288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proflavine acts as a Rev inhibitor by targeting the high-affinity Rev binding site of the Rev responsive element of HIV-1.
    DeJong ES; Chang CE; Gilson MK; Marino JP
    Biochemistry; 2003 Jul; 42(26):8035-46. PubMed ID: 12834355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of HIV Rev peptides with the Rev response element RNA.
    Williamson JR; Battiste JL; Mao H; Frankel AD
    Nucleic Acids Symp Ser; 1995; (33):46-8. PubMed ID: 8643394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allosteric inhibition of the HIV-1 Rev/RRE interaction by a 3'-methylphosphonate modified antisense oligo-2'-O-methylribonucleotide.
    Prater CE; Saleh AD; Wear MP; Miller PS
    Oligonucleotides; 2007; 17(3):275-90. PubMed ID: 17854268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV-1 RRE RNA acts as an RNA silencing suppressor by competing with TRBP-bound siRNAs.
    Daniels SM; Sinck L; Ward NJ; Melendez-Peña CE; Scarborough RJ; Azar I; Rance E; Daher A; Pang KM; Rossi JJ; Gatignol A
    RNA Biol; 2015; 12(2):123-35. PubMed ID: 25668122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.